No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy

Nodding syndrome has been suggested to be triggered by neurotoxic leiomodin-1 auto-antibodies cross-reacting with <i>Onchocerca volvulus</i>. Here, we screened serum and CSF samples of persons with nodding syndrome and other forms of onchocerciasis-associated epilepsy (OAE) and African a...

Full description

Bibliographic Details
Main Authors: An Hotterbeekx, Melissa Krizia Vieri, Melanie Ramberger, Ashraf Jozefzoon-Aghai, Michel Mandro, Floribert Tepage, Alfred Dusabimana, Samir Kumar-Singh, Maarten J. Titulaer, Robert Colebunders
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/10/7/845
id doaj-751fc968f91a465d81245d36caf75484
record_format Article
spelling doaj-751fc968f91a465d81245d36caf754842021-07-23T13:59:32ZengMDPI AGPathogens2076-08172021-07-011084584510.3390/pathogens10070845No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated EpilepsyAn Hotterbeekx0Melissa Krizia Vieri1Melanie Ramberger2Ashraf Jozefzoon-Aghai3Michel Mandro4Floribert Tepage5Alfred Dusabimana6Samir Kumar-Singh7Maarten J. Titulaer8Robert Colebunders9Global Health Institute, University of Antwerp, 2610 Antwerp, BelgiumGlobal Health Institute, University of Antwerp, 2610 Antwerp, BelgiumDepartment of Neurology, Erasmus MC University Medical Center, 3015 Rotterdam, The NetherlandsDepartment of Neurology, Erasmus MC University Medical Center, 3015 Rotterdam, The NetherlandsProvincial Health Division of Ituri, Ministry of Health, Bunia, Democratic Republic of the CongoMinistry of Health, Buta, Democratic Republic of the CongoGlobal Health Institute, University of Antwerp, 2610 Antwerp, BelgiumMolecular Pathology Group, Laboratory of Cell Biology and Histology, University of Antwerp, 2610 Antwerp, BelgiumDepartment of Neurology, Erasmus MC University Medical Center, 3015 Rotterdam, The NetherlandsGlobal Health Institute, University of Antwerp, 2610 Antwerp, BelgiumNodding syndrome has been suggested to be triggered by neurotoxic leiomodin-1 auto-antibodies cross-reacting with <i>Onchocerca volvulus</i>. Here, we screened serum and CSF samples of persons with nodding syndrome and other forms of onchocerciasis-associated epilepsy (OAE) and African and European controls for leiomodin-1 antibodies by a cell-based assay (CBA) and Western blot (WB). These samples were also investigated for the presence of auto-antibodies cross-reacting with rat brain tissue by immunohistochemistry (IHC). Additionally, IHC was used to detect the leiomodin-1 protein in post-mortem brain samples of persons with OAE who died. Leiomodin-1 antibodies were detected by CBA in 6/52 (12%) and by WB in 23/54 (43%) persons with OAE compared to in 14/61 (23%) (<i>p =</i> 0.113) and 23/54 (43%) <i>(p =</i> 0.479) of controls without epilepsy. Multivariable exact logistic regression did not show an association between <i>O. volvulus</i> infection or epilepsy status and the presence of leiomodin-1. Leiomodin-1 antibodies were not detected in 12 CSF samples from persons with OAE or in 16 CSF samples from persons with acute-onset neurological conditions, as well as not being detected in serum from European controls. Moreover, the leiomodin-1 protein was only detected in capillary walls in post-mortem brain tissues and not in brain cells. IHC on rat brain slides with serum samples from persons with OAE or controls from persons with or without <i>O. volvulus</i> infection revealed no specific staining pattern. In conclusion, our data do not support OAE to be an autoimmune disorder caused by leiomodin-1 antibodies.https://www.mdpi.com/2076-0817/10/7/845onchocerciasis-associated epilepsynodding syndromeleiomodin-1autoimmune
collection DOAJ
language English
format Article
sources DOAJ
author An Hotterbeekx
Melissa Krizia Vieri
Melanie Ramberger
Ashraf Jozefzoon-Aghai
Michel Mandro
Floribert Tepage
Alfred Dusabimana
Samir Kumar-Singh
Maarten J. Titulaer
Robert Colebunders
spellingShingle An Hotterbeekx
Melissa Krizia Vieri
Melanie Ramberger
Ashraf Jozefzoon-Aghai
Michel Mandro
Floribert Tepage
Alfred Dusabimana
Samir Kumar-Singh
Maarten J. Titulaer
Robert Colebunders
No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
Pathogens
onchocerciasis-associated epilepsy
nodding syndrome
leiomodin-1
autoimmune
author_facet An Hotterbeekx
Melissa Krizia Vieri
Melanie Ramberger
Ashraf Jozefzoon-Aghai
Michel Mandro
Floribert Tepage
Alfred Dusabimana
Samir Kumar-Singh
Maarten J. Titulaer
Robert Colebunders
author_sort An Hotterbeekx
title No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
title_short No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
title_full No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
title_fullStr No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
title_full_unstemmed No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
title_sort no evidence for the involvement of leiomodin-1 antibodies in the pathogenesis of onchocerciasis-associated epilepsy
publisher MDPI AG
series Pathogens
issn 2076-0817
publishDate 2021-07-01
description Nodding syndrome has been suggested to be triggered by neurotoxic leiomodin-1 auto-antibodies cross-reacting with <i>Onchocerca volvulus</i>. Here, we screened serum and CSF samples of persons with nodding syndrome and other forms of onchocerciasis-associated epilepsy (OAE) and African and European controls for leiomodin-1 antibodies by a cell-based assay (CBA) and Western blot (WB). These samples were also investigated for the presence of auto-antibodies cross-reacting with rat brain tissue by immunohistochemistry (IHC). Additionally, IHC was used to detect the leiomodin-1 protein in post-mortem brain samples of persons with OAE who died. Leiomodin-1 antibodies were detected by CBA in 6/52 (12%) and by WB in 23/54 (43%) persons with OAE compared to in 14/61 (23%) (<i>p =</i> 0.113) and 23/54 (43%) <i>(p =</i> 0.479) of controls without epilepsy. Multivariable exact logistic regression did not show an association between <i>O. volvulus</i> infection or epilepsy status and the presence of leiomodin-1. Leiomodin-1 antibodies were not detected in 12 CSF samples from persons with OAE or in 16 CSF samples from persons with acute-onset neurological conditions, as well as not being detected in serum from European controls. Moreover, the leiomodin-1 protein was only detected in capillary walls in post-mortem brain tissues and not in brain cells. IHC on rat brain slides with serum samples from persons with OAE or controls from persons with or without <i>O. volvulus</i> infection revealed no specific staining pattern. In conclusion, our data do not support OAE to be an autoimmune disorder caused by leiomodin-1 antibodies.
topic onchocerciasis-associated epilepsy
nodding syndrome
leiomodin-1
autoimmune
url https://www.mdpi.com/2076-0817/10/7/845
work_keys_str_mv AT anhotterbeekx noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy
AT melissakriziavieri noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy
AT melanieramberger noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy
AT ashrafjozefzoonaghai noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy
AT michelmandro noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy
AT floriberttepage noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy
AT alfreddusabimana noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy
AT samirkumarsingh noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy
AT maartenjtitulaer noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy
AT robertcolebunders noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy
_version_ 1721286565185978368